• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢癌组织学亚型的转移模式。一项尸检研究。

Metastatic patterns in histologic variants of ovarian cancer. An autopsy study.

作者信息

Rose P G, Piver M S, Tsukada Y, Lau T S

机构信息

Department of Gynecologic Oncology and Pathology, Roswell Park Memorial Institute, Buffalo, New York 14263.

出版信息

Cancer. 1989 Oct 1;64(7):1508-13. doi: 10.1002/1097-0142(19891001)64:7<1508::aid-cncr2820640725>3.0.co;2-v.

DOI:10.1002/1097-0142(19891001)64:7<1508::aid-cncr2820640725>3.0.co;2-v
PMID:2776109
Abstract

The autopsy findings of 428 patients with various histologic types of ovarian cancer were studied to determine if metastatic patterns were different. Epithelial tumors were the most frequent (89%), followed by sarcomas (7.2%). Germ cell and stromal tumors each occurred in 1.9% of cases. Sites of metastasis were nearly identical, with no statistical difference among histologic types. The peritoneum was most frequently involved (83% to 100% of cases), but lymph node metastasis was common (50% to 60% of cases). Metastasis was more common to the paraaortic lymph nodes than to the pelvic lymph nodes. In seven of eight stromal tumors, hepatic metastasis was present but did not cause the patient's death. For epithelial tumors, metastasis to distant sites was dependent on nodal and intraperitoneal disease. However, this was not true in the 31 ovarian sarcomas or the series of germ cell or stromal tumors. This finding supports a hematogenous route of metastasis for ovarian sarcomas. Understanding the metastatic potential of ovarian cancer is important in designing effective treatment regimens.

摘要

对428例不同组织学类型的卵巢癌患者的尸检结果进行研究,以确定转移模式是否存在差异。上皮性肿瘤最为常见(89%),其次是肉瘤(7.2%)。生殖细胞肿瘤和性索间质肿瘤各占病例的1.9%。转移部位几乎相同,不同组织学类型之间无统计学差异。腹膜受累最为常见(83%至100%的病例),但淋巴结转移也很常见(50%至60%的病例)。转移至腹主动脉旁淋巴结比盆腔淋巴结更常见。在8例性索间质肿瘤中的7例中,存在肝转移,但未导致患者死亡。对于上皮性肿瘤,远处转移取决于淋巴结和腹腔内病变。然而,在31例卵巢肉瘤或生殖细胞肿瘤或性索间质肿瘤系列中并非如此。这一发现支持卵巢肉瘤的血行转移途径。了解卵巢癌的转移潜能对于设计有效的治疗方案很重要。

相似文献

1
Metastatic patterns in histologic variants of ovarian cancer. An autopsy study.卵巢癌组织学亚型的转移模式。一项尸检研究。
Cancer. 1989 Oct 1;64(7):1508-13. doi: 10.1002/1097-0142(19891001)64:7<1508::aid-cncr2820640725>3.0.co;2-v.
2
[A study on the distribution of metastases at autopsy in 70 patients with ovarian cancer].[一项关于70例卵巢癌患者尸检时转移灶分布的研究]
Nihon Sanka Fujinka Gakkai Zasshi. 1994 Apr;46(4):337-44.
3
Patterns of metastasis in uterine sarcoma. An autopsy study.
Cancer. 1989 Mar 1;63(5):935-8. doi: 10.1002/1097-0142(19890301)63:5<935::aid-cncr2820630525>3.0.co;2-9.
4
Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma.低恶性潜能的卵巢浆液性肿瘤伴淋巴结低级别浆液性癌。
Am J Surg Pathol. 2012 Jul;36(7):955-63. doi: 10.1097/PAS.0b013e31825793e1.
5
Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors.卵巢癌中的淋巴结转移:浆液性和非浆液性原发性肿瘤之间的差异
Gynecol Oncol. 2005 Nov;99(2):427-31. doi: 10.1016/j.ygyno.2005.06.051. Epub 2005 Aug 19.
6
Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.明显早期上皮性卵巢癌淋巴结转移的危险因素:对手术分期的影响。
Gynecol Oncol. 2011 Sep;122(3):536-40. doi: 10.1016/j.ygyno.2011.05.001. Epub 2011 Jun 1.
7
Recent developments on the significance and pathogenesis of lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors).低恶性潜能卵巢浆液性肿瘤(交界性肿瘤)中淋巴结受累的意义及发病机制的最新进展
Int J Gynecol Cancer. 2009 Jan;19(1):103-8. doi: 10.1111/IGC.0b013e3181991a49.
8
Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary.卵巢原发性和复发性颗粒细胞瘤的腹膜后淋巴结转移
Gynecol Oncol. 2006 Oct;103(1):31-4. doi: 10.1016/j.ygyno.2006.01.050. Epub 2006 Mar 13.
9
Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer.与早期卵巢癌淋巴结转移原发部位相关的淋巴绘图及前哨淋巴结识别
Gynecol Oncol. 2004 Jul;94(1):161-6. doi: 10.1016/j.ygyno.2004.04.023.
10
Lymph node metastasis of ovarian cancer: a preliminary survey of 74 cases of lymphadenectomy.卵巢癌淋巴结转移:74例淋巴结切除术的初步调查
Am J Obstet Gynecol. 1986 Nov;155(5):1103-8. doi: 10.1016/0002-9378(86)90359-5.

引用本文的文献

1
Cancer microbiota: a focus on tumor-resident bacteria.癌症微生物群:聚焦肿瘤驻留细菌。
EMBO Rep. 2025 May 28. doi: 10.1038/s44319-025-00482-w.
2
Isolated Liver Recurrence After Cytoreduction in High-Grade Serous Ovarian Carcinoma: Experience of a Tertiary Center in Turkey.高级别浆液性卵巢癌肿瘤细胞减灭术后孤立性肝转移:土耳其一家三级中心的经验
J Clin Med. 2025 Mar 7;14(6):1791. doi: 10.3390/jcm14061791.
3
High-grade serous cancer of left fallopian tube with right inguinal lymph node enlargement: a case report.左侧输卵管高级别浆液性癌伴右侧腹股沟淋巴结肿大:一例报告
Front Oncol. 2025 Feb 6;15:1486688. doi: 10.3389/fonc.2025.1486688. eCollection 2025.
4
Serous Ovarian Carcinoma: Detailed Analysis of Clinico-Pathological Characteristics as Prognostic Factors.浆液性卵巢癌:作为预后因素的临床病理特征详细分析
Cancers (Basel). 2024 Oct 25;16(21):3611. doi: 10.3390/cancers16213611.
5
Chemoembolization, Radioembolization, and Percutaneous Ablation: New Opportunities for Treating Ovarian Cancer Liver Metastasis.化疗栓塞术、放射性栓塞术和经皮消融术:治疗卵巢癌肝转移的新机会。
Curr Treat Options Oncol. 2024 Nov;25(11):1428-1437. doi: 10.1007/s11864-024-01266-5. Epub 2024 Oct 19.
6
Case report: Axillary lymph node metastases from primary ovarian cancer: a report of two cases and literature review.病例报告:原发性卵巢癌腋窝淋巴结转移:两例报告及文献复习
Front Oncol. 2024 May 21;14:1384306. doi: 10.3389/fonc.2024.1384306. eCollection 2024.
7
Macrophage Checkpoint Nanoimmunotherapy Has the Potential to Reduce Malignant Progression in Bioengineered Models of Ovarian Cancer.巨噬细胞检查点纳米免疫疗法有潜力降低生物工程卵巢癌模型中的恶性进展。
ACS Appl Bio Mater. 2024 Dec 16;7(12):7871-7882. doi: 10.1021/acsabm.4c00076. Epub 2024 Apr 1.
8
Cerebellar metastasis of ovarian cancer: a case report.卵巢癌小脑转移:一例报告。
J Med Case Rep. 2023 Dec 19;17(1):553. doi: 10.1186/s13256-023-04211-6.
9
Ang-2 is a potential molecular marker for lymphatic metastasis and better response to bevacizumab therapy in ovarian cancer.血管生成素-2 是卵巢癌淋巴转移和对贝伐珠单抗治疗反应更好的潜在分子标志物。
J Cancer Res Clin Oncol. 2023 Nov;149(17):15957-15967. doi: 10.1007/s00432-023-05354-1. Epub 2023 Sep 8.
10
A medley of resistance in ovarian cancers.卵巢癌中的耐药混合情况。
Nat Genet. 2023 Mar;55(3):361-362. doi: 10.1038/s41588-023-01303-3.